Skip to main content
Publications
Ahmadizar F, Fortuny J , Royo AC, Plana E , Weinrib R , Garcia Esteban R , Boric K , Yefimenko N, Haugh M, Carreras JJ, Urchueguia-Fornes A, Correcher E, van den Berg JM, Lysen T, Villalobos F, Bissacco CA, Newbern EC, Willame C, Praet N, Sturkenboom MCJM. Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European healthcare data sources: methods and results of the second study feasibility assessment . Poster presented at the 2024 ISPE Annual Meeting; August 27, 2024. Berlin, Germany.
Saigi-Morgui N , Rebordosa C , Plana E , Rubino A, Aguado J , Martinez D , Lei A, Daoud SZ, McMahon P, Perez-Gutthann S , Rivero-Ferrer E . Acute myocardial infarction, stroke, and MACE in COPD patients treated with aclidinium and other inhaled bronchodilators . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Forns J , Dudukina E, Hagg D, Szentkuti EP, Gembert K, Plana E , Gilsenan A , Horvath-Puho E, Reutfors J, Rebordosa C . Cohort study of the incidence of major cardiovascular events in new adult users of lisdexamfetamine and remote adult users of other attention-deficit/hyperactivity disorder treatments . Poster presented at the 2021 8th World Congress on ADHD Virtual Event; May 6, 2021.
Rivero-Ferrer E , Witzleb AJ, Olesen M, Plana E , Aguado J , Saigi-Morgui N , Rubino A, Daoud SZ, Lei A, Perez-Gutthann S , Schink T, Kristiansen NS, Pottegard A, Rebordosa C . Are aclidinium and aclidinium/formoterol used according to their approved indication in Europe? Results of a multicountry drug utilization postauthorization safety study . Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Gilsenan A , Fortuny J , Plana E , Ruigomez A, Karlsson P, Flynn RWV, Cantero OF, Garcia-Rodriguez L, Linner L, Cainzos-Achirica M, Bartsch J , MacDonald T, Kieler H, Andrews EB. Non-interventional cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort initiating polyethylene glycol 3350 (PEG) . Poster presented at the 2018 Digestive Disease Week; June 3, 2018. Washington, DC.
Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, Schlienger R, de Groot MCH, Plana E , Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Gil M, Huerta C, Alvarez A, de Abajo F, Hesse U, Fischer R, Hasford J, Gerlach R, Tauscher M, Reynolds R, Klungel OH, Schmiedl S. Time trends in prevalence of inhaled long-acting beta-2-adrenoceptor agonist prescribing – A comparison of seven European electronic health record databases . Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2013; August 2013. Montreal, Canada.
Geissbühler Y, Butzkueven H, Hernández-Diaz S, Koren G, MacDonald T, Tilson H, Starzyk K, Plana E , Cremer M, von Rosenstiel P, Anand D, Schlosshauer R, Yuanyuan L, Hellwig K. Multinational gilenya™ (fingolimod) pregnancy exposure registry: preliminary results . Poster presented at the American Academy of Neurology's 65th AAN Annual Meeting; March 2013. San Diego, CA.